CVE-2021-27660
C-CURE 9000
An insecure client auto update feature in C-CURE 9000 can allow remote execution of lower privileged Windows programs.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
8.8
C-CURE 9000
An insecure client auto update feature in C-CURE 9000 can allow remote execution of lower privileged Windows programs.
- Record
CVE-2021-27660- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-20
- Updated
- 2026-11-02
EUVDEUVD-2021-14406
8.8
An insecure client auto update feature in C-CURE 9000 can allow remote execution of lower privileged Windows programs.
- Record
EUVD-2021-14406- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-2cfq-h45g-8h84 No score
An insecure client auto update feature in C-CURE 9000 can allow remote execution of lower...
An insecure client auto update feature in C-CURE 9000 can allow remote execution of lower privileged Windows programs.
- Record
GHSA-2cfq-h45g-8h84- Weakness
- CWE-20
- Updated
- 2026-11-02
NVD
8.8
An insecure client auto update feature in C-CURE 9000 can allow remote execution of lower privileged Windows programs.
- Record
CVE-2021-27660- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 6.5 Medium
AV:N/AC:L/Au:S/C:P/I:P/A:P - Weakness
- CWE-20
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2021-27660 is a high vulnerability (CVSS 8.8) in Johnson Controls C-cure 9000, published July 1, 2021. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 2.10%, the 81st percentile. No source names a fixed version.